Financhill
Back

Amgen, Inc. Stock Predictions

Amgen, Inc. Stock Forecast

  • Over the next 52 weeks, Amgen, Inc. has on average historically risen by 27.2% based on the past 42 years of stock performance.
  • Amgen, Inc. has risen higher in 27 of those 42 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
  • Is Amgen, Inc. Stock Undervalued?
    The current Amgen, Inc. [AMGN] share price is $341.88. The Score for AMGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • AMGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Amgen, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Amgen, Inc. has on average historically risen by 27.2% based on the past 42 years of stock performance.

Amgen, Inc. Stock Rating

Sell
47
Amgen, Inc. (AMGN) is a Sell

Is Amgen, Inc. overpriced?

  • Amgen, Inc. has risen higher in 27 of those 42 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%

Amgen, Inc. Stock Price History

Is AMGN stock going to rise?

  • The current trend is moderately bullish and AMGN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amgen.com

52-Week Data

52-Week High:
353.25
52-Week Low:
261.43

Prediction Charts

Market Cap:
184.1B
Price in USD:
341.88
Volume:
2.5M
Beta:
0.75

Technical Analysis

SMA50:
333.15
SMA100:
314.65
SMA200:
300.99
52-Wk Change:
20.37%

Stock Predictions

  • Is Amgen, Inc. stock public?
    Yes, Amgen, Inc. is a publicly traded company.
  • What is the Amgen, Inc. stock quote today?
    The Amgen, Inc. stock price is 341.88 USD today.
  • How to buy Amgen, Inc. stock online?
    You can buy Amgen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-12 328.47 325.54 328.47 322.74
Jan-13 327.42 324.30 327.75 319.79
Jan-14 324.09 328.97 329.20 323.55
Jan-15 328.97 330.03 332.50 325.19
Jan-16 328.70 330.41 333.03 326.90
Jan-20 325.58 331.00 331.34 321.71
Jan-21 329.95 343.60 343.98 329.32
Jan-22 344.15 347.07 349.98 342.14
Jan-23 346.18 344.75 349.23 341.82
Jan-26 344.70 349.69 350.43 343.62
Jan-27 348.57 351.32 353.25 346.93
Jan-28 349.00 342.22 351.95 340.00
Jan-29 341.66 342.94 347.27 338.75
Jan-30 340.81 341.88 345.50 338.07

Amgen, Inc. Earnings

Amgen, Inc. Earnings Report: Per Share Amgen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amgen, Inc. Forecast Revenue Growth

Amgen, Inc. Stock Analysis: Historical quarterly revenues per share for Amgen, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $0.68 per share.

* Amgen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.